Filings Radar

SEC 8-K filings, classified by Claude with reasoning. Updated nightly from EDGAR's daily index (~10 PM ET).

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

Jasper Therapeutics, Inc.

Exec departure confidence 75% filed 2026-05-21 Item 5.02

Christian Nolet resigned from the Board of Directors effective May 15, 2026. While the filing also mentions the appointment of Svetlana Lucas to the Audit Committee, the principal disclosed action is Nolet's departure from the Board. Board departures are material to investors as they affect governance and oversight. The explicit statement that the resignation is not due to disagreement mitigates some concern but does not eliminate materiality.

View raw filing on EDGAR →

Chenghe Acquisition III Co.

Exec appointment confidence 85% filed 2026-05-21

The filing discloses the appointment of Zhong Li as an independent director effective May 18, 2026, with assignment to the Audit, Compensation, and Nominating and Corporate Governance Committees. While the filing also mentions the concurrent resignation of Ningrong Liu, the substantive disclosure centers on the appointment of a new director with detailed background information highlighting his 20+ years of experience in finance, regulation, and technology across multiple jurisdictions and institutions. For a SPAC, director appointments are material governance events affecting investor assessment of board composition and oversight capability.

View raw filing on EDGAR →

Ondas Inc.

M&A activity confidence 98% filed 2026-05-21

The filing discloses the completion of a material acquisition of Omnisys Ltd. for an aggregate purchase price of $196.6 million in Ondas Inc. common stock, with 100% of Omnisys's issued and outstanding shares acquired pursuant to a Share Purchase Agreement dated May 16, 2026. Item 2.01 explicitly states "Completion of Acquisition or Disposition of Assets," and the transaction is clearly material to investors given its substantial size and the significant equity consideration involved.

View raw filing on EDGAR →

Greenland Mines Ltd

M&A activity confidence 95% filed 2026-05-21

The filing discloses entry into an Agreement and Plan of Merger on May 20, 2026, whereby Neo North Star Resources, Inc. will merge into Greenland Rare Earths Corp., a wholly owned subsidiary of Greenland Mines Ltd. The consideration totals $35 million ($20 million cash and $15 million in newly issued common stock), representing a material acquisition transaction. This is a classic Item 1.01 disclosure of entry into a material agreement constituting M&A activity.

View raw filing on EDGAR →

Amanat Acquisition Corp.

Other material confidence 65% filed 2026-05-21 Item 1.01

This disclosure describes Amanat Acquisition Corp.'s consummation of an IPO on May 18, 2026, generating $75 million in gross proceeds from 7.5 million Class A shares at $10 per share, along with entry into multiple ancillary agreements (underwriting, trust, registration rights, private placement, and indemnification agreements). While the IPO itself is a material capital-raising event, it does not fit cleanly into the standard 8-K taxonomy—it is neither an earnings release, M&A activity, nor a traditional "material definitive agreement" in the sense of a business transaction. The event is material to investors but lacks a dedicated category, warranting classification as other_material.

View raw filing on EDGAR →

Amanat Acquisition Corp.

Dilutive issuance confidence 95% filed 2026-05-21 Item 3.02

The filing discloses a private placement of 300,000 Class A Ordinary Shares to the Sponsor at $10.00 per share, generating $3,000,000 in gross proceeds. This is a classic unregistered equity issuance under Item 3.02, typical of SPAC sponsor investments. The shares are subject to transfer restrictions and redemption waivers, and the transaction is material to investors assessing the company's capitalization and sponsor alignment.

View raw filing on EDGAR →

Amanat Acquisition Corp.

Exec appointment confidence 95% filed 2026-05-21 Item 5.02

The disclosure centers on the appointment of three independent directors (Rakhi Kumar, Brad Middlekauff, and Patrick Crutcher) to the board in connection with the IPO on May 18, 2026, along with their concurrent appointments to key board committees (Audit, Compensation, and Nominating and Corporate Governance). This is a material governance event for a newly public company establishing its board structure.

View raw filing on EDGAR →

Amanat Acquisition Corp.

Other material confidence 45% filed 2026-05-21 Item 5.03

The filing discloses an amendment to the Company's articles of incorporation (Amended Charter filed with the Cayman Islands General Registry on May 18, 2026) in connection with the IPO. While Item 5.03 is a standard disclosure vehicle for charter amendments, the materiality here turns on whether this is a routine administrative filing or a substantive governance change. The reference to IPO context and incorporation of terms "set forth in the Registration Statement on pages 151 to 153" suggests this may be a material governance restructuring tied to going public, but the 8-K excerpt itself provides no detail on what changed or why it matters to investors. Without visibility into the actual charter terms, confidence is moderate; this could be either a routine IPO-related formality or a material governance event.

View raw filing on EDGAR →

Amanat Acquisition Corp.

Other material confidence 65% filed 2026-05-21 Item 8.01

This disclosure describes the mechanics of a SPAC's IPO trust account structure and the conditions governing release of $75 million in proceeds. While the IPO itself is a material capital-raising event, the filing does not present it as an earnings release or discrete M&A activity, but rather as a disclosure of trust account governance and redemption mechanics under Item 8.01 (Other Events). The most accurate classification is other_material, as it describes a material financing event that does not fit neatly into the more specific categories.

View raw filing on EDGAR →

Crown PropTech Acquisitions

M&A activity confidence 95% filed 2026-05-21 Item 1.01

This disclosure reports Amendment No. 2 to a business combination agreement between Crown PropTech Acquisitions (SPAC) and Mkango Rare Earths Limited, filed under Item 1.01 (Entry into a Material Definitive Agreement). The amendment modifies key terms of the underlying business combination, including the Exchange Ratio, share issuances, and intercompany debt settlement conditions. The filing also amends the Registration Rights and Lock-Up Agreement to be executed at Closing. These modifications to a material acquisition agreement constitute M&A activity material to investors assessing the transaction structure and terms.

View raw filing on EDGAR →

Crown PropTech Acquisitions

M&A activity confidence 95% filed 2026-05-21 Item 7.01

The filing discloses the public filing of a Form F-4 registration statement relating to a proposed Business Combination between Crown PropTech Acquisitions (SPAC) and MKAR (Mkango Resources). This represents a material M&A activity—specifically a SPAC merger/change of control transaction. The disclosure explicitly references "the proposed Business Combination and certain other transactions contemplated under the Business Combination Agreement," which is the hallmark of ma_activity under Items 1.01 or 2.01.

View raw filing on EDGAR →

KPET Ultra Paceline Corp

Other material confidence 65% filed 2026-05-21

The filing discloses that unit holders may elect to separately trade Class A ordinary shares and warrants commencing May 21, 2026, with separated securities trading under distinct NYSE symbols (KPET and KPET.WS). This is a structural change affecting the trading and composition of the company's securities, which would materially affect investor options and the total mix of information available. However, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or other defined event type), warranting classification as other_material.

View raw filing on EDGAR →

Twenty One Capital, Inc.

Other material confidence 72% filed 2026-05-21 Item 5.03

The filing discloses amendments to the Company's Certificate of Formation and Bylaws that remove references to SoftBank and a Governance Agreement (terminated May 19, 2026), and add an election under Texas Business Organizations Code Section 21.419. While Item 5.03 covers articles and bylaw amendments, the material substance here is the termination of a governance arrangement with significant parties (Tether Investments, SoftBank, and Bitfinex), which represents a material change in control or governance structure rather than routine administrative housekeeping. This does not fit cleanly into the specific event taxonomy but is material to investors assessing the Company's governance and stakeholder relationships.

View raw filing on EDGAR →

Twenty One Capital, Inc.

Shareholder vote confidence 75% filed 2026-05-21 Item 5.07

Item 5.07 is the designated Item for shareholder vote results. Although the prose is minimal and incorporates Item 5.03 by reference (which typically covers amendments to articles/bylaws), the Item 5.07 caption and the reference structure indicate this disclosure concerns matters submitted to a shareholder vote. The materiality depends on what Item 5.03 contains, but shareholder votes on governance matters are generally material to investors.

View raw filing on EDGAR →

KOHLS Corp

Exec Compensation confidence 95% filed 2026-05-21 Item 5.02

This disclosure reports shareholder approval of the Kohl's Corporation 2024 Long-Term Compensation Plan, as amended and restated effective May 20, 2026. The filing explicitly states "The Plan is a material compensatory arrangement in which the Company's named executive officers are eligible to participate" and details material amendments including a 5.2 million share authorization increase, a ten-year plan extension through 2036, and a $750,000 annual compensation cap for non-employee directors. This is a classic exec_compensation event involving shareholder approval of a compensatory plan arrangement.

View raw filing on EDGAR →

KOHLS Corp

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a clear disclosure of shareholder voting results from the Annual Meeting held on May 20, 2026, covering four proposals: election of eight directors, advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as independent auditor, and approval of the amended 2024 Long-Term Compensation Plan. The filing explicitly states "The results detailed below represent final voting results," which is the hallmark of Item 5.07 shareholder vote results disclosure.

View raw filing on EDGAR →

RADIAN GROUP INC

Exec appointment confidence 95% filed 2026-05-21 Item 5.02

The filing discloses the appointment of Michael Weinbach as CEO-Elect effective June 1, 2026, and subsequently as Chief Executive Officer and Board member effective August 13, 2026, succeeding retiring CEO Richard G. Thornberry. While the section also covers compensatory arrangements (base salary of $1,000,000, STI target of $1,166,666, and LTI awards totaling $6,000,000 plus sign-on equity), the principal disclosed action is Weinbach's appointment to the CEO role and the Board, making this an executive appointment event.

View raw filing on EDGAR →

Veritone, Inc.

Dilutive issuance confidence 92% filed 2026-05-21 Item 1.01

Veritone entered into an at-the-market (ATM) equity offering agreement with three sales agents authorizing the sale of up to $50 million in common stock shares. This is a registered dilutive issuance under Rule 415(a)(4) that would materially affect existing shareholders through potential equity dilution and is a significant capital-raising activity for the company.

View raw filing on EDGAR →

FONAR CORP

M&A activity confidence 92% filed 2026-05-21 Item 8.01

This Item 8.01 disclosure centers on supplemental disclosures related to a previously announced merger agreement between FONAR Corporation and entities controlled by CEO Timothy Damadian. The filing updates the Definitive Proxy Statement and Schedule 13E-3/A filed on April 16, 2026, in connection with a special stockholder meeting scheduled for May 28, 2026, to vote on the proposed merger. While the Item is technically "Other Events," the substance is material M&A activity—specifically, supplemental disclosures addressing stockholder litigation allegations regarding disclosure deficiencies in the merger proxy materials. The company voluntarily supplemented disclosures to avoid litigation risks and allow stockholders to vote on the merger.

View raw filing on EDGAR →

Whitehawk Therapeutics, Inc.

Other material confidence 72% filed 2026-05-21 Item 8.01

The disclosure announces an option agreement with Hangzhou DAC Biotechnology providing access to a linker-payload (CPT113) for up to five additional ADC programs, which expands the Company's pipeline. While this represents a material strategic development for a biotech company's product pipeline, it does not fit cleanly into the more specific event categories (not an M&A transaction, not an earnings release, not an executive change, and not a financial impairment or covenant breach). The pipeline expansion through a licensing/option agreement is material to investors assessing the company's future prospects but is best classified as other_material.

View raw filing on EDGAR →

Sensei Biotherapeutics, Inc.

Shareholder vote confidence 45% filed 2026-05-21 Item 8.01

This disclosure announces an upcoming stockholder vote on the conversion of Series B Preferred Stock that would trigger a change of control under Nasdaq rules (>20% dilution and control change per Rules 5635(a) and 5635(b)). However, the filing is pre-meeting notice rather than post-meeting results. The material substance is the announced change-of-control transaction requiring shareholder approval, which more closely aligns with ma_activity (change of control), though the Item 8.01 placement and focus on the voting mechanics creates ambiguity about the intended classification.

View raw filing on EDGAR →

Relay Therapeutics, Inc.

Dilutive issuance confidence 95% filed 2026-05-21 Item 1.01

Relay Therapeutics entered into an Underwriting Agreement on May 20, 2026, for an underwritten public offering of 22,916,667 shares at $12.00 per share, with underwriters exercising a full 30-day option for an additional 3,437,500 shares, generating approximately $296.8 million in net proceeds. This is a material registered equity issuance that dilutes existing shareholders and materially affects the company's capital structure and investor assessment.

View raw filing on EDGAR →

Quince Therapeutics, Inc.

Delisting risk confidence 95% filed 2026-05-21 Item 8.01

The Company disclosed receipt of a Nasdaq notice on March 17, 2026 that it had failed to maintain the minimum market value of listed securities ($50 million) required under Nasdaq Listing Rule 5450(b)(2)(A). Although the Company subsequently regained compliance by May 20, 2026 based on stockholders' equity meeting Rule 5450(b)(1)(A), the disclosure centers on a delisting risk event—the failure to satisfy a continued listing rule and the subsequent resolution. This is material to investors as it directly affects the Company's ability to remain listed on Nasdaq.

View raw filing on EDGAR →

Olema Pharmaceuticals, Inc.

Other material confidence 72% filed 2026-05-21 Item 7.01

The disclosure announces preliminary clinical data from a Phase 1 study of OP-3136, a KAT6 inhibitor. While this is clinical progress for a biopharmaceutical company, it does not fit neatly into the standard taxonomy categories. It is not an earnings release (no financial results), not an exec change, not M&A, and not a restatement or going-concern issue. Clinical trial data announcements are material to investors in biotech companies as they affect pipeline value and investor sentiment, but lack a dedicated event type; therefore "other_material" is most appropriate.

View raw filing on EDGAR →

Olema Pharmaceuticals, Inc.

Other material confidence 75% filed 2026-05-21 Item 8.01

The disclosure announces preliminary Phase 1 clinical data for OP-3136, a drug candidate in development, showing favorable safety, tolerability, and early efficacy signals (tumor shrinkage in 13/19 patients, 3 partial responses, no dose-limiting toxicities). While this is material clinical progress for a biopharmaceutical company, it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, impairment, or litigation). The announcement of positive Phase 1 data would affect a reasonable investor's assessment of the company's pipeline and prospects, warranting classification as a material event outside the standard taxonomy.

View raw filing on EDGAR →

Hims & Hers Health, Inc.

M&A activity confidence 92% filed 2026-05-21 Item 1.01

Hims & Hers issued $402.5 million in convertible notes on May 21, 2026, pursuant to an indenture with U.S. Bank Trust Company. This represents a material capital-raising transaction that materially affects the company's capital structure and financial obligations. While the notes are debt instruments rather than a traditional M&A transaction, Item 1.01 "Entry Into a Material Definitive Agreement" is the appropriate disclosure vehicle for material financing arrangements, and the $402.5 million principal amount and convertible features (with initial conversion price of $29.53 per share) constitute a material event affecting investors' assessment of the registrant's financial position and dilution risk.

View raw filing on EDGAR →

Hims & Hers Health, Inc.

Other material confidence 45% filed 2026-05-21 Item 2.03

Item 2.03 discloses creation of a direct financial obligation, with the substance incorporated by reference from Item 1.01 ("Indenture and Notes"). Without access to the Item 1.01 content, the specific nature of the obligation cannot be determined—it could be debt issuance (ma_activity if part of a financing transaction), a covenant breach trigger, or another material event. The reference structure prevents confident classification into a more specific category.

View raw filing on EDGAR →

Hims & Hers Health, Inc.

Dilutive issuance confidence 95% filed 2026-05-21 Item 3.02

This Item 3.02 discloses an unregistered sale of convertible notes (the "Notes") to qualified institutional buyers under Rule 144A, with a maximum of 18,057,397 shares of Class A common stock potentially issuable upon conversion. The disclosure explicitly references Section 4(a)(2) and Rule 144A exemptions, and notes that conversion shares would be issued under Section 3(a)(9). This is a classic dilutive issuance — a private placement of convertible securities that will result in equity dilution to existing shareholders upon conversion.

View raw filing on EDGAR →

FMC CORP

Other material confidence 72% filed 2026-05-21 Item 8.01

FMC announced the pricing of a $1.2 billion offering of Senior Secured Notes due 2031. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financial position, it does not fit cleanly into the taxonomy's more specific categories (ma_activity applies to acquisitions/dispositions/mergers, not debt offerings; dilutive_issuance applies to equity securities). The disclosure is material but best classified as other_material given the debt financing nature.

View raw filing on EDGAR →

LSB INDUSTRIES, INC.

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This Item 5.07 filing discloses the final voting results from LSB Industries' 2026 annual meeting of stockholders held on May 21, 2026. The section presents detailed vote tallies for three matters: election of three director nominees (Jonathan Z. Ackerman, Diana M. Peninger, and Lynn F. White), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, and the directors were duly elected to serve until 2029.

View raw filing on EDGAR →

LSB INDUSTRIES, INC.

M&A activity confidence 85% filed 2026-05-21 Item 8.01

LSB Industries announced on May 18, 2026 that it will assume full ownership of a carbon capture and sequestration project from Lapis Carbon Solutions, with total consideration and remaining capital estimated at approximately $95 million. This constitutes a material acquisition or change of control of the Project, meeting the threshold for ma_activity disclosure under Item 8.01 (Other Events), with contingent consideration tied to milestone achievement.

View raw filing on EDGAR →

CHOICE HOTELS INTERNATIONAL INC /DE

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a classic Item 5.07 disclosure of shareholder vote results from an Annual Meeting. The filing reports voting outcomes on four proposals: (1) election of eleven directors, (2) advisory vote on executive compensation, (3) amendment to Certificate of Incorporation to expand Board size range, and (4) ratification of Ernst & Young LLP as independent auditor. All proposals passed with substantial majorities, making this a material governance event that investors rely on to assess board composition and corporate oversight.

View raw filing on EDGAR →

WILLIS TOWERS WATSON PLC

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This Item 5.07 disclosure reports the results of Willis Towers Watson's 2026 Annual General Meeting held on May 20, 2026, including voting outcomes on director elections, auditor ratification, executive compensation approval, share issuance authorities, and employee share plan amendments. The filing presents detailed vote tallies for each proposal, which is the core content of shareholder vote results disclosures required under Item 5.07.

View raw filing on EDGAR →

EagleRock Land, LLC

Other material confidence 45% filed 2026-05-21 Item 1.01

The filing discloses entry into a "Material Definitive Agreement" (Item 1.01) and incorporates by reference information from Item 2.03 regarding a "Joinder Agreement" under "Predecessor Credit Facility." Without access to the Item 2.03 details, the nature of the agreement cannot be precisely determined—it could relate to debt covenant modifications, credit facility amendments, or other financial arrangements. The reference to a "Joinder Agreement" and "Predecessor Credit Facility" suggests a credit-related transaction, but the specific materiality and event classification depend on details not provided in this excerpt.

View raw filing on EDGAR →

EagleRock Land, LLC

Other material confidence 65% filed 2026-05-21 Item 2.03

This Item 2.03 discloses the creation of direct financial obligations in connection with EagleRock's IPO closing: assumption of a $263.3 million Predecessor Credit Facility (maturing July 3, 2027) and entry into a new $200 million revolving Credit Facility with JPMorgan Chase. While Item 2.03 is the designated section for debt obligations, the event does not fit cleanly into the taxonomy's more specific categories (covenant_breach, dilutive_issuance, ma_activity). The disclosure is material to investors assessing the company's capital structure and leverage post-IPO, but the primary event is debt assumption and new financing rather than a breach, impairment, or other discrete triggering event.

View raw filing on EDGAR →

Verisk Analytics, Inc.

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a classic Item 5.07 disclosure of shareholder vote results from Verisk Analytics' 2026 Annual Meeting held on May 19, 2026. The filing presents detailed voting tallies for four proposals: election of eleven board directors, say-on-pay advisory vote, auditor ratification, and a shareholder proposal on written consent rights. The comprehensive vote counts and named director nominees are unmistakable indicators of shareholder meeting results.

View raw filing on EDGAR →

BRUKER CORP

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a clear disclosure of shareholder vote results from Bruker Corporation's 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing reports final vote tallies for three proposals: election of Class II directors (Laura A. Francis, John J. Phillips, Hermann F. Requardt), advisory approval of 2025 named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. This is a quintessential Item 5.07 disclosure of shareholder voting outcomes, which is material to investors as it reflects governance decisions and stakeholder approval of key corporate matters.

View raw filing on EDGAR →

Kraft Heinz Co

M&A activity confidence 75% filed 2026-05-21 Item 1.01

Kraft Heinz issued €1 billion in aggregate principal amount of senior notes on May 21, 2026, pursuant to a shelf registration statement. While this is a debt issuance rather than a traditional M&A transaction, the filing discloses entry into a material definitive agreement (the Fourteenth Supplemental Indenture) and the proceeds are explicitly earmarked for a concurrent tender offer to repurchase outstanding senior notes due 2046 and 2049. This debt refinancing activity—combining new issuance with debt repurchase—constitutes a material capital structure transaction that would affect a reasonable investor's assessment of the company's financial position and leverage profile.

View raw filing on EDGAR →

Kraft Heinz Co

Other material confidence 45% filed 2026-05-21 Item 2.03

Item 2.03 discloses creation of a direct financial obligation through issuance of Notes, incorporating Item 1.01 by reference. Without access to Item 1.01 details, the nature of the obligation cannot be precisely determined—it could represent debt financing, a covenant breach trigger, or another material event. The reference to Note issuance suggests a financing activity, but the specific materiality and event classification depend on the underlying transaction details in Item 1.01.

View raw filing on EDGAR →

Kraft Heinz Co

Other material confidence 72% filed 2026-05-21 Item 7.01

Kraft Heinz disclosed early tender results and pricing terms for a $1.1 billion debt tender offer to repurchase its 2046 and 2049 Senior Notes. While this is a material capital management activity affecting the company's debt structure and financial position, it does not fit cleanly into the M&A taxonomy (which focuses on acquisitions, dispositions, and changes of control) nor any other specific event type. The tender offer is a significant refinancing/debt management event material to investors assessing the company's capital strategy and leverage.

View raw filing on EDGAR →

ONTO INNOVATION INC.

Dilutive issuance confidence 75% filed 2026-05-21 Item 1.01

Onto Innovation issued $1.7 billion in aggregate principal amount of 0.00% Convertible Senior Notes due 2031 on May 21, 2026, with a conversion rate of 2.6192 shares per $1,000 principal amount (initial conversion price ~$381.80). The notes are convertible into common stock under specified circumstances, creating significant dilution potential. While this is technically debt issuance, the convertible feature and the substantial equity component make it a dilutive capital raise, fitting the dilutive_issuance category more closely than a pure debt event.

View raw filing on EDGAR →

ONTO INNOVATION INC.

M&A activity confidence 75% filed 2026-05-21 Item 2.03

Item 2.03 discloses creation of a direct financial obligation and incorporates Item 1.01 by reference. Item 1.01 typically covers material acquisitions, dispositions, or changes of control. The cross-reference structure indicates a significant transaction creating financial obligations, most likely M&A activity. Without access to Item 1.01 content, ma_activity is the most probable classification given the Item 2.03 context and incorporation language.

View raw filing on EDGAR →

ONTO INNOVATION INC.

Dilutive issuance confidence 95% filed 2026-05-21 Item 3.02

Item 3.02 discloses an unregistered sale of convertible notes issued to qualified institutional buyers under Rule 144A, with a maximum of 5,893,200 shares of Common Stock potentially issuable upon conversion at a conversion rate of 3.9288 shares per $1,000 principal. This is a classic dilutive issuance involving convertible securities that will result in equity dilution to existing shareholders upon conversion.

View raw filing on EDGAR →

ONTO INNOVATION INC.

Dilutive issuance confidence 85% filed 2026-05-21 Item 8.01

The filing discloses pricing of convertible notes ("Notes") with net proceeds of approximately $205 million used to repurchase 805,325 shares at $254.53 per share. The convertible notes are explicitly stated to be "issuable upon conversion," indicating a dilutive equity instrument. This is a material capital-raising event affecting the company's capital structure and shareholder equity.

View raw filing on EDGAR →

SCHWAB CHARLES CORP

Other material confidence 75% filed 2026-05-21 Item 8.01

Charles Schwab issued $2.25 billion in aggregate principal amount of senior notes ($1 billion at 4.744% due 2030 and $1.25 billion at 5.493% due 2037) with net proceeds of approximately $2.236 million. This is a material debt issuance that does not fit the dilutive_issuance category (which applies to equity securities) and is not a covenant breach, restatement, or other more specific event type. The disclosure of a substantial debt offering is material to investors assessing the registrant's capital structure and financial position.

View raw filing on EDGAR →

COHEN & STEERS, INC.

Exec appointment confidence 95% filed 2026-05-21 Item 5.02

The filing discloses the appointment of Amit Muni as Executive Vice President and Chief Financial Officer effective June 8, 2026, succeeding Michael Donohue. While the disclosure includes detailed compensatory terms (base salary of $450,000, guaranteed bonuses of $2,050,000 for 2026-2027, RSU awards), the principal disclosed action is the appointment of a named executive to a C-suite officer role. The compensation details are ancillary to the appointment itself.

View raw filing on EDGAR →

COHEN & STEERS, INC.

Exec appointment confidence 95% filed 2026-05-21 Item 7.01

The filing discloses Mr. Muni's appointment as Executive Vice President and Chief Financial Officer, succeeding Mr. Donohue. This is a material executive appointment to a senior financial leadership role. While the disclosure is furnished under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 5.02, the substance is clearly an executive appointment of a named officer to a key position.

View raw filing on EDGAR →

EAGLE MATERIALS INC

Exec Compensation confidence 75% filed 2026-05-21 Item 5.02

While the section discloses both an executive departure (William R. Devlin retiring as Chief Accounting Officer effective June 1, 2026) and an appointment (Samuel M. Guzman Jr. becoming Senior Vice President, Chief Accounting Officer and Controller), the bulk of the Item 5.02 disclosure centers on Item 5.02(e) compensatory arrangements. The Compensation Committee approved three incentive compensation programs (Eagle Plan, Business Unit Plan, and Special Situation Program) with specific bonus pools, performance metrics, and maximum bonus potentials for named executive officers. The compensation disclosure is more extensive and material than the succession narrative, making exec_compensation the most salient classification.

View raw filing on EDGAR →

Third Coast Bancshares, Inc.

Exec Compensation confidence 92% filed 2026-05-21 Item 5.02

The disclosure centers on shareholder approval of an amended and restated omnibus incentive plan that increases share reserves by 375,000 shares, adds vesting requirements, and modifies equity award terms. This is a compensatory arrangement disclosure under Item 5.02(e), affecting the framework for director and officer equity compensation. The material increase in authorized shares and modification of plan terms would affect investor assessment of dilution and executive incentive structures.

View raw filing on EDGAR →

Third Coast Bancshares, Inc.

Shareholder vote confidence 95% filed 2026-05-21 Item 5.07

This is a clear disclosure of shareholder vote results from the Company's Annual Meeting of Shareholders held on May 21, 2026. The filing reports voting outcomes on three matters: (1) election of directors to the board in Classes A and C, (2) approval of the Restated Plan, and (3) ratification of Whitley Penn LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Vote) for each item are the hallmark of Item 5.07 disclosures and directly match the shareholder_vote_results event type.

View raw filing on EDGAR →